Cyclophosphamide treatment improves microvessel damage in systemic sclerosis.

Abstract excerpt

The objective of this study is to evaluate nailfold videocapillaroscopy changes in scleroderma patients treated regularly on cyclic basis with iloprost and to find associations with clinical, serologic, and pharmacological variables. Forty-nine patients affected by systemic sclerosis (44 women and five men, mean age 52.4 years, mean disease duration 8.0 years, 31 patients with limited cutaneous subset and 18 with...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Azathioprine
• Share to Cyclophosphamide